Pattern play: Edwards Lifesciences

Upside breakout from a descending broadening wedge pattern.

New Highs 1

Edwards Lifesciences (EW), a designer and manufacturer of medical devices for heart disease, broke out to the upside of a descending broadening wedge pattern on December 22nd, after price held just below the upper trendline for a few weeks. The RSI is over 60 and appears to have broken out to the upside of a sideways channel. The simple moving averages (SMAs) are arranged in a bullish manner, as the 20-day SMA is above the 50-day SMA and the 50-day SMA is above the 200-day SMA. The next Fibonacci resistance levels are at 97.50 and 102.75. If price slips then traders should look to the upper trendline for support, as it recently acted as a strong resistance level. If price drops below the upper trendline of the pattern then 83.00 and 78.50 would be the immediate support levels.  



Source: GAIN Capital, TradingView

Build your confidence risk free

More from Technical Analysis

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.